临床双聘教授
第一作者论文：
(1) Jihao Zhou, Yushi Yao, Lixin Wang, Jia Wang, Yonghui Li, Mengmeng Jiang, Minhang Zhou, Xiaoning Gao, Ruisheng Li, Lili Wang, Li Yu*, Demethylating agent decitabine induces autologous cancer testis antigen specific cytotoxic T lymphocytes in vivo, Chinese Medical Journal, 2013, 126(23): 4552-4556. (IF 1.585)
(2) Jihao Zhou, Yonghui Li, Yushi Yao, Lixin Wang, Li Gao, Xiaoning Gao, Xufeng Luo, Jingxin Li, Mengmeng Jiang, Minhang Zhou, Lili Wang, Li Yu*, The cancertestis antigen NXF2 is activated by the hypomethylating agent decitabine in acute leukemia cells in vitro and in vivo, Molecular Medicine Reports, 2013, 8(5): 1549-1555. (IF 2.100)
(3) Jihao Zhou, Yayin Zhou, Jinli Wen, Xiongfei Sun, Xinyou Zhang; Circulating myeloid-derived suppressor cells predict disease activity and treatment response in patients with immune thrombocytopenia; Brazilian Journal of Medical and Biological Research; 2017, 50(2): e5637. (IF 2.023)
(4) Jihao Zhou, Yushi Yao, Qi Shen, Guoqiang Li, Lina Hu, Xinyou Zhang; Demethylating agent decitabine disrupts tumor-induced immune tolerance by depleting myeloid-derived suppressor cells; Journal of Cancer Research and Clinical Oncology; 2017; 143(8): 1371-1380. (IF 3.656)
(5) Jihao Zhou, Peng Zhu, Xinyou Zhang; A Chineses family with congenital Dysfibrinogenemia carries a heterozygous missense mutation in FGA: Conserning the genetic abnormality and clinical treatment; Pakistan Journal of Medical Sciences; 2017; 33(4): 968-972. (IF 0.754)
(6) Jihao Zhou, Haiqing Lin, Qi Shen, Lina Hu, Guoqiang Li, Xiongfei Sun, Xinyou Zhang; Comparison of mitoxantrone in combination with intermediate-dose cytarabine versus high-dose cytarabine as consolidation therapies for young non-APL acute myeloid leukemia patients with favorable and intermediate cytogenetics; Current Medical Sciences; 2018, 38(1): 51-57. (IF 1.151)
(7) Jihao Zhou, Qi Shen, Haiqing Lin, Lina Hu, Guoqiang Li, Xinyou Zhang; Decitabine shows potent anti-myeloma activity by depleting monocytic myeloid-derived suppressor cells in the myeloma microenvironment; Journal of Cancer Research and Clinical Oncology; 2019; 145(2), 329-336. (IF 3.656)
(8) Jihao Zhou, Lina Hu, Min Zuo, Yaying Zhou, Guoqiang Li, Xinyou Zhang; An Uncommon Case of Double-Hit Mantle Cell Lymphoma that Demonstrate a Transformation Process; American Journal of Clinical Pathology. 2020 Jan 1;153(1):49-57. (IF 2.094)
(9) Jihao Zhou, Min Zuo, Lifeng Li, Fang Li, Peng Ke, Yangying Zhou, Yaping Xu, Xuan Gao, Yanfang Guan, Xuefeng Xia, Xin Yi, Xinyou Zhang, Yuhua Huang. PIM1 and CD79B Mutation Status Impacts the Outcome of Primary Diffuse Large B-Cell Lymphoma of the CNS. Front Oncol. 2022, Feb 9;12:824632. doi: 10.3389/fonc.2022.824632. (IF 5.738)
(10) 周继豪，克晓燕；老年急性髓系白血病的治疗；中华血液学杂志，2009，30（1）：68-70。
(11) 周继豪，赵伟，王继军，景红梅，刘彦，陈渝萍，克晓燕；小剂量及标准剂量化疗治疗老年急性髓系白血病的疗效研究；白血病.淋巴瘤,2009，18（12）：725-728。
(12) 周继豪，孙雄飞，林海清，许瑞莲，林晓鸥，孙璇，张新友；成人轻中型珠蛋白生成障碍性贫血患者铁负荷相关并发症的回顾性分析；临床血液学杂志；2015，28（5）:423-425。
(13) 周继豪，孙璇，林海清，孙雄飞，姜容，张新友；母细胞性浆细胞样树突状细胞肿瘤一例并文献复习；白血病.淋巴瘤；2015，24（5）:294-301。
共同第一作者论文：
(1) Peng Ke, Xiebing Bao, Jihao Zhou, Qian Zhu, Juan Zhuang, Xiaohui Hu, Yuejun Liu, Depei Wu, Shengli Xue, Xinyou Zhang, Xiao Ma. Central Nervous System Complications after Allogeneic Hematopoietic Stem Cell Transplantation in Children. Acta Haematol. 2019 Oct 9:1-7. doi:10.1159/000499651. [Epub ahead of print] (共同第一作者) (IF 1.196)
(2) Peng Ke, Xiebing Bao, Jihao Zhou, Xiaoli Li, Juan Zhuang, Xuefeng He, Depei Wu, Xinyou Zhang, Xiao Ma; Donor CMV-Specific Cytotoxic T Lymphocytes Successfully Treated Drug-Resistant Cytomegalovirus Encephalitis After Allogeneic Hematopoietic Stem Cell Transplantation. Hematology. 2020, 25(1):43-47. doi: 10.1080/16078454.2019.1710945. (共同第一作者) (IF 1.650)
(3) Xueting Ye, Yun Yang, Jihao Zhou, Ling Xue, Long Wu, Peiwu Huang, Chun Feng, Peng Ke, An He, Guoqiang Li, Yuan Li, Yangqiu Li, Henry Lam, Xinyou Zhang, Ruijun Tian; Combinatory strategy using nanoscale proteomics and machine learning for T cell subtyping in peripheral blood of single multiple myeloma patients; Analytica Chimica Acta, 1173(15), August 2021, 338672. (共同第一作者) (IF 5.977)
(4) Chen Jiang, Liyun Huang, Jihao Zhou, Zhiming Li, Yu Wang, Shuo Li, Jianchang Fu, Qitao Huang, Qin Yan, Yuyuan Huang, Min Zuo, Shimin Hu, Robert Peter Gale, Yang Liang, Jingping Yun, Yuhua Huang; Epstein-Barr virus-based prognostic model in nodular sclerosis classic Hodgkin lymphoma, iScience, 2024, 27(1): 108630. (共同第一作者) (IF=5.8)
(5) Zheng Liuhai, Wang Huifang, Zhou Jihao, Shi Guangwei, Ma Jingbo, Jiang Yuke, Dong Zhiyu, Li Jiexuan, He Yuanqiao, Wu Dinglan, Sun Jichao, Xu Chengchao, Li Zhijie, Wang Jigang. Off-the-shelf CAR-NK cells targeting immunogenic cell death marker ERp57 execute robust antitumor activity and have a synergistic effect with ICD inducer oxaliplatin. J Immunother Cancer. 2024 Jul 4;12(7):e008888. doi: 10.1136/jitc-2024-008888. PMID: 38964787. (共同第一作者) (IF=10.9)
(6) Lu Jialing, Bao Xiebing, Zhou Jihao, Li Xiaoli, He Zhewei, Ji Yujie, Xue Shengli, Chen Suning, Wu Depei, Hu Qi, Ke Peng, Ma Xiao. Safety and efficacy of blinatumomab as bridge-to-transplant for B-cell acute lymphoblastic leukemia in first complete remission with no detectable minimal residual disease. Blood Cancer J. 2024 Aug 23;14(1):143. doi: 10.1038/s41408-024-01127-2. PMID: 39179531; PMCID: PMC11344091. (共同第一作者) (IF=12.8)
通讯作者论文：
(1) 胡丽娜，谢勉，李国强，冯春，柯鹏，张新友，周继豪；P-GEMOX方案一线治疗原发鼻外鼻型NK/T细胞淋巴瘤临床观察；白血病.淋巴瘤,2020，29（3）：160-164。
(2) 胡丽娜，谢勉，李国强，冯春，柯鹏，张新友，周继豪；血液肿瘤化疗后粒缺伴发热患者一线经验性抗感染治疗的临床疗效和治疗费用观察；中国感染控制杂志,2020，19（8）：715-720。
(3) Peng Ke, Xinyou Zhang, Songbai Liu, Qian Zhu, Xiao Ma, Feng Chen, Xiaowen Tang, Yue Han, ZhengZheng Fu, Suning Chen, Depei Wu, Huiying Qiu, Jihao Zhou, Xiebing Bao; The time-dependent effects of early-onset Epstein-Barr viremia on adult acute leukemia patients following allo-HSCT with ATG-containing MAC regimen; Ann Hematol. 2021 Apr 22. doi: 10.1007/s00277-021-04528-6. (共同通讯作者) (IF 2.904)
(4) 陈婷婷，张新友，周继豪；弥漫大B细胞淋巴瘤的临床及分子分型研究进展；广东医学，2022,43(2): 156-161.
(5) Tingting Chen, Chun Feng, Xinyou Zhang, Jihao Zhou; TAFRO Syndrome: A Disease that Known is Half Cured. Hematol Oncol. 2022;1‐13. https://doi.org/10.1002/hon.3075. (IF 4.85)
(6) Xiao Qiu, Jiahe Zhang, Ying Xu, Yixuan Cao, Ruiting Zhang, Lina Hu, Jihao Zhou. Identification of FCER1G as a key gene in multiple myeloma based on weighted gene co-expression network analysis. Hematology. 2023 Dec;28(1):2210904. doi:10.1080/16078454.2023.2210904. (IF 2.264)
(7) 邬京松，张新友，周继豪；异基因造血干细胞移植术后肝损伤的诊治进展；白血病.淋巴瘤,2024，33（3）：189-191。
(8) Jingsong Wu, Xiaohan Zhang, Baozhen Qin, Xiao Qiu, Xinyou Zhang, Hongyu Zhang, Xin Du, Lihua Sun, Yun Cai, Jihao Zhou. Incidence, Etiology and Prognosis of Initial Liver Injury After Allogeneic Hematopoietic Stem Cell Transplantation: A Multi-Center Retrospective Study. Transplant Proc. 2024 Jul 6:S0041-1345(24)00354-3. doi:10.1016/j.transproceed.2024.05.030. Epub ahead of print. PMID: 38972762. (IF 0.9)
(9) Xiaowen Zhang, Ang Jia, Jianwei You, Zixuan Zhuang, Yinfei Wang, Ting Liu, Xingrong Du, Linzhang Huang, Peng Li, Tong-Jin Zhao, Craig T Jordan, Li Chen, Jihao Zhou, Haobin Ye. Purine metabolites regulate leukemic cell sensitivity toward cytarabine. Haematologica. 2025 Jan 9. doi: 10.3324/haematol.2024.286308. Epub ahead of print. (IF 10.1)
(10) Qiuyuan Xiang, Min Zuo, Jihao Zhou, Chun Feng. EBV-positive diffuse large B cell lymphoma secondary to activated phosphoinositide 3 kinase δ syndrome type 1 (APDS1): a case report and literature review. Front Immunol. 2025 May 8:16:1583405. doi: 10.3389/fimmu.2025.1583405. eCollection 2025. (IF 5.7)
(11) Yanlian Liang, Wenqiang Qu, Jialing Lu, Yaopeng Liang, Wenxia Xia, Shuang Liang, Liyan Sun, Xiongchi Tang, Peng Ke, Jihao Zhou; Establishment and application of a new method for the detection of drug antibodies by flow cytometry. Transfusion. 2025 May 27. doi: 10.1111/trf.18284. Epub ahead of print. PMID: 40423088. (IF 2.5)
(12) 李俊，胡丽娜，邱骁，孙熊滨，周继豪；含泽布替尼一线方案治疗弥漫大B细胞淋巴瘤的临床观察；罕少疾病杂志，2025,32（3）：156-158,164。DOI: 10.3969/j.issn.1009-3257.2025.3.056。
(13) Qiuyuan Xiang, Jingsong Wu, Ling Huang, Tingbo Liu, Zhigang Peng, Li’e Lin, Xiaolei Wei, Hongyu Zhang, Yun Lin, Guowei Li, Yirong Jiang, Hua Wang, Keqian Shi, Xiao Qiu, Wenyu Li, Jihao Zhou; Real-world data on clinical outcomes and validation of prognostic models for angioimmunoblastic T-cell lymphoma: a multicentric retrospective study in Southern China. Front. Oncol. 2025, 15: 1580370. doi: 10.3389/fonc.2025.1580370 (IF 3.5)
(14) Ling Huang, Yong Yang, Zhenyu Zhao, Shengsheng Zhou, Jingsong Wu, Ning Wang, Fen Zhang, Keqian Shi, ChengPing Li, Xiaolei Wei, Hongyu Zhang, Yun Lin, Guowei Li, Hui Zhou, Hanguo Guo, Xinmiao Jiang, Xiaojuan Wei, Feili Chen, Sichu Liu, Caidi Lin, Zhanli Liang, Yilan Huang, Lu Pan, Hui Yang, Yirong Jiang, Yudan Wu, Shuqin Cheng, Huifang Yang, Xiaoqiang Zheng, Xinggui Chen, Xiaoliang Li, Guinian Huang, Jihao Zhou, Zhigang Peng, Li-e Lin, Tingbo Liu, Wenyu Li; Clinical characteristics, treatment patterns, and survival outcomes of 1031 patients with peripheral T cell lymphoma in china: a multicenter, real-world study. Discov Oncol. 2025 Jul 2;16(1):1252. doi: 10.1007/s12672-025-02980-8. PMID: 40601115. (IF 2.9)
其他作者论文：
(1) Yonghui Li, Li Gao, Xufeng Luo,Lili Wang, Xiaoning Gao, Wei Wang, Junzhong Sun, Liping Dou, Jingxin Li, Chengwang Xu, Lixin Wang, Minhang Zhou, Mengmeng Jiang, Jihao Zhou, Michael A Caligiuri, Clara Nervi, Clara D Bloomfield, Guido Marcucci, Li Yu*, Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway, Blood, 2013, 121(3): 499-509.
(2) Yushi Yao, Jihao Zhou, Lixin Wang, Xiaoning Gao, Qiaoyang Ning, Mengmeng Jiang, Jia Wang, Lili Wang, Li Yu*, Increased PRAME-specific CTL killing of acute myeloid leukemia cells by either a novel histone deacetylase inhibitor chidamide alone or combined treatment with decitabine, PLos One, 2013,8(8): e70522-e70522.
(3) Lixin Wang, Zhenyang Mei, Jihao Zhou, Yushi Yao, Yonghui Li, Yihan Xu, Jingxin Li, Xiaoning Gao, Minhang Zhou, Mengmeng Jiang, Li Gao, Yi Ding, Xuechun Lu, Jinlong Shi, Xufeng Luo, Jia Wang, Lili Wang, Chunfeng Qu, Xuefeng Bai, Li Yu*, Low dose decitabine treatment induces CD80 expression in cancer cells and stimulates tumor specific cytotoxic T lymphocyte responses, PLos One, 2013, 8(5): e62924-e62924.
(4) Xiaoning Gao, Ji Lin, Qiaoyang Ning, Li Gao, Yushi Yao, Jihao Zhou, Yonghui Li, Lili Wang, Li Yu*; A histone acetyltransferase p300 inhibitor C646 induces cell cycle arrest and apoptosis selectively in AML1-ETO-positive AML cells, PLos One, 2013, 8(2): e55481-e55481.
(5) Yu Jing, Xiangshu Jing, Lixin Wang, Liping Dou, Quanshun Wang, Yushi Yao, Shimei Lian, Jihao Zhou, Haiyan Zhu, Zilong Yao, Lijun Gao, Lili Wang, Yonghui Li, Xuefeng Bai, Meiyun Fang, Li Yu.* Decitabine-based chemotherapy followed by haploidentical lymphocyte infusion improves the effectiveness in elderly patients with acute myeloid leukemia, Oncotarget, 2016, Aug 10. doi: 10.18632/oncotarget.11183. [Epub ahead of print]
(6) Yushi Yao, Lei Wang, Jihao Zhou, Xinyou Zhang; HIF-1α inhibitor echinomycin reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect; Journal of Translational Medicine; 2017, 15:28. doi: 10.1186/s12967-017-1132-9.
(7) Lihong Zhang, Haifei Yang, Chongsheng Qian, Jihao Zhou, Qian Zhu, Yibin Jiang, Shuo Liu, Xiaochen Chen, Ting Xu, Changju Qu, Caixia Li, Zhengming Jin, Jianhong Chu, Xinyou Zhang, Depei Wu, Haiwen Huang. Efficacy and toxicity of SEAM (semustine, etoposide, cytarabine, and melphalan) conditioning regimen followed by autologous stem cell transplantation in lymphoma. Hematology. 2022 Dec;27(1):404-411. doi: 10.1080/16078454.2022.2051864. PMID: 35413224.
(8) Xiaoping Yi, Huien Zhan, Jun Lyu, Juan Du, Min Dai, Min Zhao, Yu Zhang, Cheng Zhou, Xin Xu, Yi Fan, Lin Li, Baoxia Dong, Xinya Jiang, Zeyu Xiao, Jihao Zhou, Minyi Zhao, Jian Zhang, Yan Fu, Tingting Chen, Yang Xu, Jie Tian, Qifa Liu, Hui Zeng; A chest CT-based nomogram for predicting survival in acute myeloid leukemia. BMC Cancer. 2024;24(1):458. Published 2024 Apr 12. doi:10.1186/s12885-024-12188-8
(9) Izel Okcu, Yucai Wang, Allison M. Bock, Jihao Zhou, Muhamad Alhaj Moustafa, Han W. Tun, Allison C. Rosenthal, Patrick B. Johnston, Firas Baidoun, Arushi Khurana, Brian F. Kabat, Rebecca L. King, Thomas M. Habermann, Grzegorz S. Nowakowski. Incidence of Central Nervous System Relapse in Primary Mediastinal Large B-Cell Lymphoma: Implications for Central Nervous System Prophylaxis. Clinical Lymphoma, Myeloma and Leukemia, Published: August 01, 2024, DOI:https://doi.org/10.1016/j.clml.2024.07.019.
(10) Edward R Scheffer Cliff, Guido D Pelaez, Fei Wan, Varun Iyengar, Jihao Zhou, Kevin Chung, Nayef Abdel-Razeq, Jessica Allen, Ajay Major, John Sharp, Narendranath Epperla, Patrick Gould, Hua-Jay J Cherng, Samin Houshyar, Danielle S Wallace, Ryan C Lynch, Avyakta Kallam, Matthew G Mei, Reid W Merryman, Michelle Fleyshman, Joanna M Rhodes, Adam Kidwell, Timothy S Fenske, Nikita Malakhov, Erin Mulvey, Marcus P Watkins, Muhamad Alhaj Moustafa, Talal Hilal, Grzegorz S Nowakowski, Yucai Wang, Pallawi Torka, David A Russler-Germain; Cell-Of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B Cell Lymphoma. Clin Cancer Res. 2025 Oct 27. doi: 10.1158/1078-0432.CCR-25-2392. Epub ahead of print. PMID: 41143601.
参编著作：
1. 临床移植实践及血液肿瘤诊断与治疗，云南科技出版社，2019年第一版（副主编）
2. 淋巴瘤靶向及免疫治疗手册，清华大学出版社，2023年第一版（编者）
参编指南和共识：
1. 大湾区血液病中西医结合诊疗专家共识，人民卫生出版社，2025年（编者），
2. 造血干细胞移植临床实践整体评估中国专家共识(2025年版)，中国医学前沿杂志 (电子版)，2025，17（6）：1-13.（编者）
3. Chinese expert consensus on the management of patients with hematologic malignancies infected with SARS-CoV-2; J Cancer Res Ther; 19(6):1495-1500. (编者)
(4) 粤港澳大湾区多发性骨髓瘤骨病中西医诊疗专家共识; 中华中医药学刊；2025（编者）
会议摘要：
(1) Jihao Zhou, Min Zuo, Peng Ke, Qi Shen, Lifeng Li, Yaping Xu, Lina Hu, Guoqiang Li, Chun Feng, Xuan Gao, Yanfang Guan, Xuefeng Xia, Xinyou Zhang, Yuhua Huang; AACR 2021, Abstract 666: PIM1 and CD79b mutation status impact outcome in primary central nervous system DLBCL after high-dose methotrexate-based chemoimmunotherapy. Cancer Res 1 July 2021; 81 (13_Supplement): 666. Doi: 10.1158/1538-7445. AM2021-666 (AACR 2021)
(2) Jihao Zhou, Jacqueline F. Wang, Steven Ray Hwang, Jonas Paludo, Javier L. Munoz, David James Inwards, Allison C. Rosenthal, William Breen, Scott Lester, Stephen M Ansell, Thomas M. Habermann, Thomas E. Witzig, Grzegorz S. Nowakowski, Yucai Wang; ASH 2023, Abstract 1666: Treatment Pattern and Survival Outcome of Limited Stage Mantle Cell Lymphoma: A National Cancer Database Analysis in Pre-BTK Inhibitor Vs BTK Inhibitor Era.
(3) Jacqueline F. Wang, Jihao Zhou, Steven R Hwang, Catherine S Diefenbach, Jia Ruan, Peter Martin, Jonas Paludo, Javier L. Munoz, Stephen M Ansell, Thomas E. Witzig, Thomas M. Habermann, James R. Cerhan, Grzegorz S. Nowakowski, Yucai Wang; ASH 2023, Abstract 1663: A National Cancer Database Study of Survival Trends in Patients with Mantle Cell Lymphoma Stratified By Age Group
(4) Man Qiao, Xiaofei Yang, Xiebing Bao, Jihao Zhou, Han Zhu, Yanming Zhang, Tao You, Huiying Qiu, Ying Wang, Shengli Xue, Aining Sun, Yue Han, Xiao Ma, Xiaojin Wu, Depei Wu, Suning Chen; ASH 2023, Abstract 4922: Sitagliptin for Prevention of aGVHD in Patients Received Alternative Donor Transplantations: A Prospective, Multicenter, Open-Label, Randomized Controlled Trial.
(5) Lipeng Chen, Qing Sun, Jihao Zhou, Guoqiang Li, Qijun Huang, Xiao Qiu, Jiahe Zhang, Chun Feng, Lina Hu, Yongjian Yue; ASH 2023, Abstract 4057: New Insights into Hematopoietic Redefinition and New Paradigms in Hematopoietic Hierarchy Roadmap.
(6) Rui Huang, Xiaonan Lin, Yuming Zhang, YongZhong Su, Caixia Wang, Jihao Zhou, Zhenqian Huang, Jinxiong Huang, Xiong Zhang, Ying Zhao, Yuexiong Liang, Xiaotao Wang, Xuekui Gu, Honghua He, Yaling Zheng, Sanfang Tu, FeiHeng Chen, Shaoze Lin, Yaya Wang, Ying Dong, Pengcheng Huang, Zenghui Liu, Xiaoli Xu, Zhao Liang, Xuan Zhou, Meifang Li, Man Luo, Ming Wu, Fang Jiang, Qin Liu, Hui Zeng, Chaoyang Song, Yuhua Li; ASH 2023, Abstract Venetoclax Plus Azacitadine for Middle Aged and Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: Interim Analysis of a Prospective, Multicenter, Single-Arm, Phase 2 Trial.
(7) Izel Okcu, Jihao Zhou, Yucai Wang, Allison Marie Bock, Muhamad Alhaj Moustafa, Firas Baidoun, Han W. Tun, Allison Claire Rosenthal, Patrick B. Johnston, Brian Kabat, Lisa M. Rimsza, Thomas Matthew Habermann, Grzegorz S. Nowakowski; ASCO 2024, Abstract 7080: Incidence of central nervous system relapse in primary mediastinal B-cell lymphoma: Implications for central nervous system prophylaxis.
(8) Tingting Chen, Jingsong Wu, Qiuyuan Xiang, Guoqiang Li, Limin Li, Jihao Zhou; EHA 2024, Abstract PB3045: R-CHOP+X regimen achieves high response rate and long-term survival benefit in the treatment of BN2 and MCD subtypes of newly diagnosed diffuse large b-cell lymphoma.
(9) Qiuyuan Xiang, Jingsong Wu, Ling Huang, Tingbo Liu, Zhigang Peng, Lie Lin, Xiaolei Wei, Hongyu Zhang, Yun Lin, Guowei Li, Yirong Jiang, Hua Wang, Keqian Shi, Wenyu Li, Jihao Zhou; EHA 2024, Abstract PB3045: Comparison of different prognostic models for angioimmunoblastic T-cell lymphoma: Real-world data from T cell lymphoma cooperation group in South China.
(10) Jie Wang, Jihao Zhou, Yucai Wang, Javier L. Munoz, Kevin G. Shim, Muhamad Alhaj Moustafa, Firas Baidou, Kaitlin Annunzio , Narendranath Epperla, Michael McLane, Yasmin H. Karimi, Binh Luu, Stephen E Spurgeon, Cheryl Chang, Zihan Wan, Diamone Gathers, Emily R. King, Marcus P. Watkins, Nancy L. Bartlett, Christine E. Ryan, Genevieve M Gerhard, Philippe Armand, Ann S. LaCasce,, Vedha Vaddaraju, Danielle S Wallace, Vaishalee P Kenkre, Chase Junge, Natalie Grover, Jorge A Florindez, Reem Karmali, Alexander V. Stanisic, Chen Zhang, Parameswaran Venugopal, Grace Ying, Caitlin Gribbin, Jia Ruan, Navika D Shukla, Sonali M. Smith, Viktoriya Zelikson, Michael E. Williams, Stefan K. Barta, Omar Elghawy, Jake Schade, Rohini Navalekar, Matthew Matasar, Andrew M Evens, Alexey V. Danilov and Timothy S. Fenske. ASH 2024, Abstract 4406: Real World First-Line Treatment Strategies and Outcomes in TP53 Mutated and Unmutated Mantle Cell Lymphoma.
(11) Jacqueline F. Wang, Jihao Zhou, Reema K. Tawfiq, Han W. Tun, Javier L. Munoz, Jonas Paludo, Muhamad Alhaj Moustafa, Steven R. Hwang, Izel Okcu, Catherine S. Diefenbach, Jia Ruan, Peter Martin, Thomas M. Habermann, Thomas E. Witzig, Grzegorz S. Nowakowski and Yucai Wang, MD. ASH 2024, Abstract 1637: Association of Sex, Race and Ethnicity with Clinical Characteristics and Survival Outcomes of Mantle Cell Lymphoma: A National Cancer Database Study.
(12) Edward Scheffer Cliff, Guido Pelaez, Fei Wan, Varun Iyengar, Jihao Zhou, Kevin Chung, Nayef Abdel-Razeq, Ajay Major, Jessica M Allen, John Sharp, Narendranath Epperla, Patrick Gould, Hua-Jay J Cherng, Samin Houshyar, Danielle S Wallace, Ryan C. Lynch, Avyakta Kallam, Matthew Mei, Reid W. Merryman, Michelle Fleyshman, Joanna M. Rhodes, Adam Kidwell, Timothy S. Fenske, Erin Mulvey, Marcus P. Watkins, Muhamad Alhaj Moustafa, Talal Hilal, Grzegorz S. Nowakowski, Yucai Wang, Pallawi Torka and David A Russler-Germain. ASH 2024, Abstract 652: The Predictive Value of Cell-of-Origin Subtype By Hans Algorithm in 718 Patients with Large B Cell Lymphoma Receiving Polatuzumab Vedotin.
(13) Nadia Toumeh, Yu Tao, Jihao Zhou, Rosalyn Marar, Jonathan Day, Steven Hwang, Yucai Wang, Richard Godby; ASH 2025, abstract 1871: Contemporary survival trends in patients with adult T-cell leukemia/lymphoma (ATLL) in the United States: Insights from the national cancer database.
(14) Olisaemeka Ogbue, Jihao Zhou, Oluwatayo Adeoye, Ayo Falade, Steven Hwang, Yucai Wang, Richard Godby; ASH 2025, abstract 1813: Real-world treatment patterns and survival in splenic marginal zone lymphoma: A national analysis in the rituximab era.
(15) Ayo Falade, Yu Tao, Olisaemeka Ogbue, Oluwatayo Adeoye, Ayodeji Johnson, Arushi Khurana, Jithma Abeykoon, Urshila Durani, Mazie Tsang, Allison Rosenthal, Talal Hilal, Javier Munoz, Patrick Johnston, Han Tun, Grzegorz Nowakowski, James Cerhan, Richard Godby, Yucai Wang, Jihao Zhou; ASH 2025, abstract 4494: Real-world treatment patterns and survival outcomes in primary CNS lymphoma: Analysis of the national cancer database.
(17) Yucai Wang, Kari Rabe, Paul Hampel, Lindsey Roeker, Jihao Zhou, Suheil Albert Atallah-Yunes, Susan Schwager, Min Shi, Curtis Hanson, Rebecca King, Cinthya Mendoza Zepeda, Saad Kenderian, Eli Muchtar, Neil Kay, Amber Koehler, Amy Behnken, Catherine Coddington, Susan Slager, Sameer Parikh; ASH 2025, abstract 5673: Pirtobrutinib versus usual care for patients with Richter transformation of chronic lymphocytic leukemia: Inverse probability of treatment weighting-based analysis of BRUIN trial and mayo observational cohort.
(18) Huixing Zhou, Long Chang, Jie Ma, Songying Zhao, Jingnan Sun, Sun Liping, Xiaoqi Qin, Hongmei Jing, Jingrong Wang, He-Bing Zhou, Xiaolei Chen, Hai Zhou, Zhenling Li, Wenrong Huang, Yi Ma, Guohong Su, Jun Luo, Guoxiang Zhang, Biyun Chen, Weiwei Tian, Guang-Yu Ma, Jihao Zhou, Wenming Chen, Hong-Hu Zhu, Jian Li, Wen Gao; ASH 2025, abstract 5830: Renal response of selinexor, bortezomib, pomalidomide, and dexamethasone in newly diagnosed multiple myeloma patients with renal impairment: A phase 2, prospective, multicenter study.